Stephane Budel is a partner at DeciBio Consulting. His role is to help life science companies bring disruptive technologies to the market.
Stephane Budel is a partner at DeciBio Consulting with over 15 years of combined experience in life science business consulting, entrepreneurship, and academic research. He specializes in the analysis of private to mid-cap companies with established to emerging technologies in the life science research tools and molecular diagnostics spaces. Dr. Budel earned his Ph.D. in Physiology from Yale University.